Arrowhead Pharmaceuticals, Inc. (LON:0HI3)
London
· Delayed Price · Currency is GBP · Price in USD 20.03
-0.79 (-3.80%)
At close: Feb 21, 2025
Arrowhead Pharmaceuticals Market Cap
Arrowhead Pharmaceuticals has a market cap or net worth of 1.99 billion as of February 21, 2025. Its market cap has decreased by -39.26% in one year.
Market Cap
1.99B
Enterprise Value
2.24B
Revenue
2.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
20.03
Market Cap Chart
Since January 13, 2004, Arrowhead Pharmaceuticals's market cap has increased from 17.94M to 1.99B, an increase of 10,962.01%. That is a compound annual growth rate of 24.96%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 179.71B |
| GSK plc | 59.06B |
| Haleon | 34.94B |
| Smith & Nephew | 8.87B |
| Hikma Pharmaceuticals | 5.06B |
| ConvaTec Group | 4.94B |
| HUTCHMED (China) | 2.06B |
| Oxford Nanopore Technologies | 1.26B |